Web Analytics

3 Latest Announced Rounds

$1,219.99M Raised in 77 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Aardvark Therapeutics

start up
United States - San Diego, California
  • 10/05/2024
  • Series C
  • $85,000,000

San Diego based pharmaceutical company specializing in gut brain interaction with a focus of inflammation and metabolism


Related People

Tien LeeFounder

Tien Lee United States - San Diego, California

Dr. Lee has over 15 years of experience as a biotechnology innovator and executive who has been integrally involved with the founding or advancement of several biopharmaceutical companies. Since 2017, Dr Lee is the founder/CEO of Aardvark Therapeutics, Inc. Prior to this, Dr. Lee joined Nantkwest in 2014 and served as its Chief Strategy Officer until March, 2017. His experience includes therapeutics for immunology, cardiovascular, oncology, neurology, and infectious disease indications. Dr. Lee is also an inventor or co-inventor of multiple biomedical and biotechnology innovations, licensed or assigned to several companies for development including Nantkwest (Nasdaq: NK), Simcere Pharmaceutical Group, Cellics Therapeutics, Sorrento Therapeutics (Nasdaq: SRNE), and Aardvark Therapeutics. Dr. Lee earned his M.D. degree from UC San Diego and his B.A. degree from UC Berkeley in Molecular Biology where he was also a Regents and Alumni Scholar. Dr. Lee received post-graduate training in Internal Medicine through UC Los Angeles and Physical Medicine and Rehabilitation at UC Irvine.